Last --
Change Today 0.00 / 0.00%
Volume 0.0
3933 On Other Exchanges
Symbol
Exchange
3933 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

the united laboratories inte (3933) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THE UNITED LABORATORIES INTE (3933)

Related News

No related news articles were found.

the united laboratories inte (3933) Related Businessweek News

No Related Businessweek News Found

the united laboratories inte (3933) Details

The United Laboratories International Holdings Limited, an investment holding company, manufactures and sells pharmaceutical products. The company operates in three segments: Intermediate Products, Bulk Medicine, and Finished Products. It offers antibiotic and non-antibiotic finished products, and soft capsules casings. The company also produces and sells bulk medicine, pharmaceutical intermediate products, and organic fertilizers. In addition, it is engaged in trading pharmaceutical products. It operates primarily in the People's Republic of China, Europe, India, Hong Kong, the Middle East, South America, and other Asian regions. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong. The United Laboratories International Holdings Limited is a subsidiary of Heren Far East Limited.

12,000 Employees
Last Reported Date: 09/25/14
Founded in 1990

the united laboratories inte (3933) Top Compensated Officers

Executive Chairman
Total Annual Compensation: $3.3M
Vice Chairman, Chief Financial Officer, Quali...
Total Annual Compensation: $3.7M
Vice President and Executive Director
Total Annual Compensation: $3.7M
Vice President and Executive Director
Total Annual Compensation: $3.6M
Vice President and Executive Director
Total Annual Compensation: $3.6M
Compensation as of Fiscal Year 2013.

the united laboratories inte (3933) Key Developments

The United Laboratories International Holdings Limited Presents at 13th Annual dbAccess China Conference, Jan-12-2015

The United Laboratories International Holdings Limited Presents at 13th Annual dbAccess China Conference, Jan-12-2015 . Venue: Grand Hyatt Hotel, Beijing, China.

The United Laboratories International Holdings Limited Presents at HSBC China Conference 2014, Oct-20-2014

The United Laboratories International Holdings Limited Presents at HSBC China Conference 2014, Oct-20-2014 . Venue: Ritz Carlton Pudong, Pudong, Shanghai Province, China.

The United Laboratories International Holdings Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

The United Laboratories International Holdings Limited announced unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, the company reported revenue of HKD 3,701,221,000, profit before taxation of HKD 790,413,000, profit for the period attributable to owners of the company of HKD 709,906,000 or HKD 43.64 per basic and diluted share compared to the revenue of HKD 3,745,899,000, profit before taxation of HKD 84,290,000, profit for the period attributable to owners of the company of HKD 42,992,000 or HKD 2.62 per diluted share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3933:HK $3.72 HKD +0.05

3933 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3933.
View Industry Companies
 

Industry Analysis

3933

Industry Average

Valuation 3933 Industry Range
Price/Earnings 8.3x
Price/Sales 0.8x
Price/Book 0.9x
Price/Cash Flow 8.3x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THE UNITED LABORATORIES INTE, please visit www.tul.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.